Pharmaceutical Technology Assessment: Perspectives from Payers

BACKGROUND: Advancements in biologics and personalized medicine and the implementation of national prescription drug policies have likely prompted payers to implement additional health technology assessment and cost-containment strategies. A payer’s decision to provide coverage for a drug and its as...

Descripción completa

Detalles Bibliográficos
Autores principales: Leung, Musetta Y., Halpern, Michael T., West, Nathan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2012
Materias:
Formulary Management
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437633/
https://www.ncbi.nlm.nih.gov/pubmed/22468734
http://dx.doi.org/10.18553/jmcp.2012.18.3.256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437633/
https://www.ncbi.nlm.nih.gov/pubmed/22468734
http://dx.doi.org/10.18553/jmcp.2012.18.3.256

Ejemplares similares